In addition, several major signaling pathways like NFκB, Wnt, and PI3K–AKT–mTOR are reported to be involved in the pathogenesis of GBM and have been used as therapeutic targets for GBM (14–16). This evidence concerns the gene NFKB1 and glioblastoma.